SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-17-009295
Filing Date
2017-10-27
Accepted
2017-10-27 14:50:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 71074
2 filename2.htm EX-10 277448
3 filename3.htm EX-10 1324688
4 GRAPHIC g445001dsp184a.jpg GRAPHIC 2581
5 GRAPHIC g445001dsp320.jpg GRAPHIC 5344
  Complete submission text file 0000950123-17-009295.txt   1685494
Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01709 | Film No.: 171159131
SIC: 2836 Biological Products, (No Diagnostic Substances)